Trading Statement

RNS Number:8253I
DawMed Systems PLC
30 November 2007

                                     DAWMED

For Immediate Release:                                          30 November 2007

                         DAWMED SYSTEMS PLC ("Company")

                           TIMING OF ANNUAL ACCOUNTS
                                      AND
                               TRADING STATEMENT

Due to the Company's installation of a new fully integrated IT system, which has
taken longer than was originally envisaged and has spanned the financial year
end, there will be an inevitable delay in the preparation and audit of the year
end accounts for the period ended 30th September 2007. The Company therefore
expects to announce its final results on or about 20 March 2008 and post the
Accounts not later than 31 March 2008 in accordance with the AIM Rules.

Whilst the prediction in the 2007 Interim Report that the second half of the
year would show an improvement over the less than anticipated performance of the
first half was fulfilled, the second half will nevertheless also report a loss,
albeit much smaller, and the overall result for the year will therefore be a
significant loss. The main contributing factors to the loss were the
considerable investment in the new IT system, the substantial costs associated
with the litigation arising from the alleged breach of contract by a trade
debtor, including its settlement during the financial year, and in particular an
unexpected and serious continuation of the dearth of NHS expenditure on capital
and revenue equipment for infection control.

That said, the mandate granted to the Healthcare Commission (an independent body
with wide powers to ensure compliance with infection control protocols by NHS
Primary Care and Hospital Trusts) is beginning to take effect and this, together
with an apparent uplift in NHS expenditure and a strong movement towards
collaboration between groups of NHS Hospital Trusts to offer larger scale group
contracts for infection control equipment and consumables, means that your
Company is busy again responding to higher levels of contract invitations with a
view to winning a reasonable proportion of such business in the current
financial year.

Enquiries: Kevin Gilmore
           Executive Chairman
           DawMed Systems plc                                    01789 740010

           Roland Cornish
           Chairman
           Beaumont Cornish Limited                              020 7628 3396

           Dominic Barretto
           Director
           Bishopsgate Communications Limited                    020 7430 1600



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
TSTQKLFLDFBEFBF